{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:57:29Z","timestamp":1778173049349,"version":"3.51.4"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA050317-S1"],"award-info":[{"award-number":["DA050317-S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA052263"],"award-info":[{"award-number":["R01 DA052263"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.neuropharm.2021.108766","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T10:53:55Z","timestamp":1629975235000},"page":"108766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Covid-19 interface with drug misuse and substance use disorders"],"prefix":"10.1016","volume":"198","author":[{"given":"I.E.","family":"Cisneros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108766_bib2","series-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108766_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000004363","article-title":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","author":"Alhazzani","year":"2020","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2021.108766_bib4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1134\/S0006297918090122","article-title":"Immunogenetic factors of neurodegenerative diseases: the role of HLA class II","volume":"83","author":"Aliseychik","year":"2018","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.neuropharm.2021.108766_bib5","first-page":"1","article-title":"Covid-19 impact on US national overdose crisis","author":"Alter","year":"2020","journal-title":"Overdose Detection Mapping Application Program"},{"key":"10.1016\/j.neuropharm.2021.108766_bib6","article-title":"The consequences of Covid-19 on the overdose epidemic: overdoses are increasing","author":"Alter","year":"2020","journal-title":"Overdose Detection Mapping Application Program"},{"key":"10.1016\/j.neuropharm.2021.108766_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.02.002","article-title":"SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders","volume":"58","author":"Amruta","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.neuropharm.2021.108766_bib8","doi-asserted-by":"crossref","first-page":"108009","DOI":"10.1016\/j.neuropharm.2020.108009","article-title":"Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration","volume":"168","author":"Anastasio","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s15010-015-0720-y","article-title":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)","volume":"43","author":"Arabi","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.neuropharm.2021.108766_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4137\/IJTR.S13256","article-title":"Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis","volume":"6","author":"Atlas","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib11","doi-asserted-by":"crossref","first-page":"27864","DOI":"10.1038\/srep27864","article-title":"Effect of cocaine on HIV infection and inflammasome gene expression profile in HIV infected macrophages","volume":"6","author":"Atluri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108766_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpsy.2020.10.004","article-title":"Are dopamine and serotonin involved in COVID-19 pathophysiology?","volume":"35","author":"Attademo","year":"2021","journal-title":"Eur. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4137\/IJTR.S10627","article-title":"Kynurenic acid metabolism in various types of brain pathology in HIV-1 infected patients","volume":"5","author":"Baran","year":"2012","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pnpbp.2015.09.001","article-title":"Opposing effects of alcohol on the immune system","volume":"65","author":"Barr","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2021.108766_bib17","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.bbi.2011.01.008","article-title":"Activation of inflammatory signaling by lipopolysaccharide produces a prolonged increase of voluntary alcohol intake in mice","volume":"25","author":"Blednov","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108766_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neuropharm.2015.03.015","article-title":"Role of interleukin-1 receptor signaling in the behavioral effects of ethanol and benzodiazepines","volume":"95","author":"Blednov","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2004.02708.x","article-title":"Voltammetric study of the control of striatal dopamine release by glutamate","volume":"91","author":"Borland","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108766_bib21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10875-020-00839-x","article-title":"Immune alterations in a patient with SARS-CoV-2-related acute respiratory distress syndrome","volume":"40","author":"Bouadma","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2009.09.001","article-title":"Immune proteins in brain development and synaptic plasticity","volume":"64","author":"Boulanger","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108766_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.npp.1301468","article-title":"Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior","volume":"33","author":"Breese","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0404.2007.00889.x","article-title":"Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas","volume":"116","author":"Brommeland","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2021.108766_bib25","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1172\/JCI141772","article-title":"Baricitinib restrains the immune dysregulation in patients with severe COVID-19","volume":"130","author":"Bronte","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2021.108766_bib26","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/156802606778522131","article-title":"Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence","volume":"6","author":"Bubar","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108766_bib27","first-page":"665","article-title":"Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2","volume":"37","author":"Bullen","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.neuropharm.2021.108766_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2019.03.003","article-title":"Brain interrupted: early life traumatic brain injury and addiction vulnerability","volume":"317","author":"Cannella","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108766_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2021.108766_bib32","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2021.108766_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1360-0443.2005.00985.x","article-title":"Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence","volume":"100","author":"Ciraulo","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2021.108766_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41386-020-00853-y","article-title":"Self-administered fentanyl profoundly impacts rat brain innate immune targets","volume":"46","author":"Cisneros","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/157016212802138832","article-title":"HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS","volume":"10","author":"Cisneros","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.neuropharm.2014.06.011","article-title":"Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes","volume":"85","author":"Cisneros","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib37","doi-asserted-by":"crossref","first-page":"593146","DOI":"10.3389\/fneur.2020.593146","article-title":"Methamphetamine activates trace amine associated receptor 1 to regulate astrocyte excitatory amino acid transporter-2 via differential CREB phosphorylation during HIV-associated neurocognitive disorders","volume":"11","author":"Cisneros","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib38","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1007\/s00213-018-5027-0","article-title":"The role of stress-reactivity, stress-recovery and risky decision-making in psychosocial stress-induced alcohol consumption in social drinkers","volume":"235","author":"Clay","year":"2018","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2021.108766_bib39","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010116","article-title":"Early postmortem brain MRI findings in COVID-19 non-survivors","volume":"95","author":"Coolen","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib144","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.neuropharm.2021.108766_bib40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1530-0277.2006.00084.x","article-title":"Cytokines and alcohol","volume":"30","author":"Crews","year":"2006","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib41","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuropharm.2013.06.030","article-title":"Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction","volume":"76 Pt B","author":"Cunningham","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24-30, 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neuropharm.2021.108766_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-4328(02)00286-3","article-title":"Nucleus accumbens shell and core dopamine: differential role in behavior and addiction","volume":"137","author":"Di Chiara","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3233\/JAD-2011-111097","article-title":"The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression","volume":"28","author":"Dobos","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2021.108766_bib45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","article-title":"Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward","volume":"68","author":"Eisenberger","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbi.2020.03.003","article-title":"Fentanyl self-administration impacts brain immune responses in male Sprague-Dawley rats","volume":"87","author":"Ezeomah","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108766_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056891","article-title":"Extracellular regulated kinase 1\/2 signaling is a critical regulator of interleukin-1\u03b2-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression","volume":"8","author":"Fields","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108766_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/hup.1251","article-title":"Immune system inflammation in cocaine dependent individuals: implications for medications development","volume":"27","author":"Fox","year":"2012","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib49","article-title":"Metabolomics profiling of critically ill coronavirus disease 2019 patients: identification of diagnostic and prognostic biomarkers","volume":"2","author":"Fraser","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.neuropharm.2021.108766_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.neuropharm.2021.108766_bib52","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1213\/ANE.0000000000004887","article-title":"Sedation of mechanically ventilated COVID-19 patients: challenges and special considerations","volume":"131","author":"Hanidziar","year":"2020","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2021.108766_bib53","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2007.11.017","article-title":"Increased MCP-1 and microglia in various regions of the human alcoholic brain","volume":"210","author":"He","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib55","series-title":"Increase in Drug Overdose Deaths Involving Cocaine: United States, 2009-2018","first-page":"1","author":"Hedegaard","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108766_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108766_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2021.108766_bib58","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fimmu.2020.00388","article-title":"Ido and kynurenine metabolites in peripheral and CNS disorders","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib59","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","article-title":"Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients","volume":"44","author":"Huengsberg","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neuropharm.2021.108766_bib60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.physbeh.2011.03.013","article-title":"Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley rat","volume":"104","author":"Hueston","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2021.108766_bib61","article-title":"Covid-19 pandemic impact on patients, families & individuals in recovery from SUD","author":"Hulsey","year":"2020","journal-title":"Addiction Policy Forum"},{"key":"10.1016\/j.neuropharm.2021.108766_bib62","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.stem.2020.09.016","article-title":"Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium","volume":"27","author":"Jacob","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2021.108766_bib63","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1212\/WNL.0000000000010111","article-title":"Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19","volume":"95","author":"Kanberg","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12740","article-title":"Cannabidiol modulates the expression of neuroinflammatory factors in stress- and drug-induced reinstatement of methamphetamine in extinguished rats","volume":"25","author":"Karimi-Haghighi","year":"2020","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9120340","article-title":"Evaluation of microglia\/macrophage cells from rat striatum and prefrontal cortex reveals differential expression of inflammatory-related mRNA after methamphetamine","volume":"9","author":"Kays","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011825","article-title":"Psychological stress-induced, Ido1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans","volume":"5","author":"Kiank","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108766_bib67","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1007\/s00018-018-2815-y","article-title":"Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response","volume":"75","author":"Klempin","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pbb.2019.01.007","article-title":"Neuroinflammation in addiction: a review of neuroimaging studies and potential immunotherapies","volume":"179","author":"Kohno","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2021.108766_bib69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","article-title":"Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement","volume":"87","author":"Koob","year":"2020","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib70","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib71","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108766_bib72","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2013.05.024","article-title":"Addiction as a stress surfeit disorder","volume":"76 Pt B","author":"Koob","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11481-014-9573-x","article-title":"Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-\u03b3 via a TNF-\u03b1\/JNK- mediated mechanism","volume":"10","author":"Kovalevich","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17155368","article-title":"Tobacco quit intentions and behaviors among cigar smokers in the United States in response to COVID-19","volume":"17","author":"Kowitt","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.neuropharm.2021.108766_bib75","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib76","first-page":"523","article-title":"Accelerated overdose deaths linked with COVID-19","volume":"325","author":"Kuehn","year":"2021","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2021.108766_bib77","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41375-020-0891-0","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","volume":"34","author":"La Ros\u00e9e","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.neuropharm.2021.108766_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/npp.2016.121","article-title":"Glial and neuroimmune mechanisms as critical modulators of drug use and abuse","volume":"42","author":"Lacagnina","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib79","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1128\/JVI.02248-06","article-title":"Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection","volume":"81","author":"Larrea","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib80","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1111\/ejn.14163","article-title":"Glial mechanisms underlying substance use disorders","volume":"50","author":"Linker","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib81","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)39275-4","article-title":"Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation","volume":"293","author":"Liu","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108766_bib82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3565(24)38877-9","article-title":"Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide","volume":"295","author":"Liu","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108766_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056306","article-title":"Partial MHC\/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction","volume":"8","author":"Loftis","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108766_bib84","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.irn.2020.09.005","article-title":"The role of gut-immune-brain signaling in substance use disorders","volume":"157","author":"Lucerne","year":"2021","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-015-1511-3","article-title":"Neurotropic virus infections as the cause of immediate and delayed neuropathology","volume":"131","author":"Ludlow","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib86","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0024-3205(02)01853-2","article-title":"Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation","volume":"71","author":"Maes","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainres.2008.01.093","article-title":"Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse","volume":"1203","author":"Mahajan","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib88","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuropharm.2004.12.010","article-title":"Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells","volume":"48","author":"Malaplate-Armand","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib89","first-page":"1872","article-title":"Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes","volume":"26","author":"Mandrekar","year":"2002","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2021.108766_bib91","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib92","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","article-title":"Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors","volume":"89","author":"Mazza","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108766_bib93","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the inflammatory response to severe COVID-19 illness","volume":"202","author":"McElvaney","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2021.108766_bib94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108766_bib95","doi-asserted-by":"crossref","first-page":"107840","DOI":"10.1016\/j.neuropharm.2019.107840","article-title":"Cocaine-induced changes in CX","volume":"162","author":"Montesinos","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib96","doi-asserted-by":"crossref","first-page":"107807","DOI":"10.1016\/j.pharmthera.2021.107807","article-title":"Addiction and the kynurenine pathway: a new dancing couple?","volume":"223","author":"Morales-Puerto","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2021.108766_bib97","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"M\u00fcller","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbr.2004.05.029","article-title":"Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice","volume":"156","author":"Nakagawa","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib99","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/jmv.25826","article-title":"An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19","volume":"92","author":"Nataf","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib1","series-title":"Provisional Death Counts for Covid-19","author":"(NCHS)","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108766_bib100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/alcalc\/agw098","article-title":"The role of NFkB in drug addiction: beyond inflammation","volume":"52","author":"Nennig","year":"2017","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2021.108766_bib101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2020.04.124","article-title":"COVID-19, SARS and MERS: a neurological perspective","volume":"77","author":"Ng Kee Kwong","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib102","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2008.06.026","article-title":"Serotonergic mechanisms in addiction-related memories","volume":"195","author":"Nic Dhonnchadha","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib103","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1089\/pop.2020.0230","article-title":"The opioid epidemic within the COVID-19 pandemic: drug testing in 2020","volume":"24","author":"Niles","year":"2021","journal-title":"Popul. Health Manag."},{"key":"10.1016\/j.neuropharm.2021.108766_bib104","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1083\/jcb.201712011","article-title":"Cocaine-induced release of CXCL10 from pericytes regulates monocyte transmigration into the CNS","volume":"218","author":"Niu","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib105","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/mp.2014.177","article-title":"DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling","volume":"20","author":"Northcutt","year":"2015","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2005.09.007","article-title":"Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome","volume":"240","author":"Nyl\u00e9n","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib107","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","article-title":"Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin","volume":"29","author":"O'Connor","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib108","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital signs: characteristics of drug overdose deaths involving opioids and stimulants - 24 states and the District of Columbia, January-June 2019","volume":"69","author":"O'Donnell","year":"2020","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.): MMWR (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.neuropharm.2021.108766_bib109","doi-asserted-by":"crossref","first-page":"861231","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2021.108766_bib110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/ene.14491","article-title":"Cytokine release syndrome-associated encephalopathy in patients with COVID-19","volume":"28","author":"Perrin","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib111","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","article-title":"Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system","volume":"90","author":"Pickering","year":"2005","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib112","article-title":"Drug overdose deaths","author":"Prevention","year":"2021","journal-title":"Opioid Overdoses"},{"key":"10.1016\/j.neuropharm.2021.108766_bib113","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108766_bib114","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2021.108766_bib115","first-page":"913","article-title":"Serum biomarkers for glioblastoma multiforme","volume":"69","author":"Quddusi","year":"2019","journal-title":"J. Pakistan Med. Assoc."},{"key":"10.1016\/j.neuropharm.2021.108766_bib116","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106230","article-title":"SARS-CoV-2 targets neurons of 3D human brain organoids","volume":"39","author":"Ramani","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2021.108766_bib117","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11481-020-09975-y","article-title":"SARS-COV2 alters blood brain barrier integrity contributing to neuro-inflammation","volume":"16","author":"Reynolds","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbi.2019.09.016","article-title":"Novel neuroimmunologic therapeutics in depression: a clinical perspective on what we know so far","volume":"83","author":"Roman","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108766_bib119","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12967-020-02534-2","article-title":"Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review","volume":"18","author":"Salajegheh Tazerji","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuropharm.2021.108766_bib120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(95)11324-P","article-title":"Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia","volume":"187","author":"Sardar","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108766_bib121","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/cei.12586","article-title":"Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients","volume":"180","author":"Schulz","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib122","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/jnc.13596","article-title":"Elevation of cortical serotonin transporter activity upon peripheral immune challenge is regulated independently of p38 mitogen-activated protein kinase activation and transporter phosphorylation","volume":"137","author":"Schwamborn","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108766_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/bs.apha.2016.01.005","article-title":"Kynurenines and glutamate: multiple links and therapeutic implications","volume":"76","author":"Schwarcz","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108766_bib125","doi-asserted-by":"crossref","first-page":"135863","DOI":"10.1016\/j.neulet.2021.135863","article-title":"HIV-1 and drug abuse comorbidity: lessons learned from the animal models of NeuroHIV","volume":"754","author":"Sil","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108766_bib126","doi-asserted-by":"crossref","first-page":"G686","DOI":"10.1152\/ajpgi.00140.2012","article-title":"Defective intestinal amino acid absorption in Ace2 null mice","volume":"303","author":"Singer","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41582-020-00453-w","article-title":"Neurological infection with SARS-CoV-2 - the story so far","volume":"17","author":"Solomon","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib128","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological features of covid-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108766_bib129","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","volume":"218","author":"Song","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2021.108766_bib130","first-page":"1","article-title":"Histopathological and inflammatory response in multiple organs of rats exposed to crack","author":"Souza","year":"2021","journal-title":"Int. J. Environ. Health Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib131","series-title":"Provisional Death Counts for Covid-19","author":"Statistics","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108766_bib132","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.neuropharm.2021.108766_bib133","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1600-0854.2008.00757.x","article-title":"Going with the flow: trafficking-dependent and -independent regulation of serotonin transport","volume":"9","author":"Steiner","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.neuropharm.2021.108766_bib134","series-title":"Provisional Death Counts for Covid-19","author":"System","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108766_bib135","doi-asserted-by":"crossref","first-page":"106754","DOI":"10.1016\/j.addbeh.2020.106754","article-title":"Substance use and abuse, COVID-19-related distress, and disregard for social distancing: a network analysis","volume":"114","author":"Taylor","year":"2021","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2021.108766_bib136","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140327","article-title":"COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status","volume":"5","author":"Thomas","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuropharm.2021.108766_bib137","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbr.2011.05.038","article-title":"Neonatal exposure to lipopolysaccharide enhances methamphetamine-induced reinstated behavioral sensitization in adult rats","volume":"224","author":"Tien","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib138","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tics.2019.03.003","article-title":"Can't or won't? Immunometabolic constraints on dopaminergic drive","volume":"23","author":"Treadway","year":"2019","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2021.108766_bib139","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0256-16.2016","article-title":"Inhibition of IKK\u03b2 reduces ethanol consumption in C57bl\/6J mice","volume":"3","author":"Truitt","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2021.108766_bib140","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1570162X14666160324124736","article-title":"Mechanisms of HIV transcriptional regulation by drugs of abuse","volume":"14","author":"Tyagi","year":"2016","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.neuropharm.2021.108766_bib141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cps.2019.12.005","article-title":"The opioid epidemic","volume":"47","author":"Upp","year":"2020","journal-title":"Clin. Plast. Surg."},{"key":"10.1016\/j.neuropharm.2021.108766_bib142","doi-asserted-by":"crossref","first-page":"19599","DOI":"10.1074\/jbc.M114.567644","article-title":"Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-\u03baB signaling and excitatory amino acid transporter-2 repression","volume":"289","author":"Vartak-Sharma","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108766_bib143","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.2174\/1381612820666140130201734","article-title":"Increase of oxidation and inflammation in nervous and immune systems with aging and anxiety","volume":"20","author":"Vida","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2021.108766_bib145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib146","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: a review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108766_bib147","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/jama.2020.17694","article-title":"Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak","volume":"324","author":"Wainwright","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2021.108766_bib148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002130050210","article-title":"Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine","volume":"130","author":"Walsh","year":"1997","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2021.108766_bib149","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.intimp.2018.01.024","article-title":"Methamphetamine modulates the production of interleukin-6 and tumor necrosis factor-alpha via the cAMP\/PKA\/CREB signaling pathway in lipopolysaccharide-activated microglia","volume":"56","author":"Wang","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2021.108766_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01443-1","article-title":"A human three-dimensional neural-perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108766_bib151","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108766_bib152","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2021.108766_bib153","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/00952990.2020.1832508","article-title":"Longer time spent at home during COVID-19 pandemic is associated with binge drinking among US adults","volume":"47","author":"Weerakoon","year":"2021","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.neuropharm.2021.108766_bib154","doi-asserted-by":"crossref","first-page":"577022","DOI":"10.1016\/j.jneuroim.2019.577022","article-title":"Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: a pilot study","volume":"335","author":"Weinstein","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-006-0562-y","article-title":"Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?","volume":"114","author":"Wu","year":"2007","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2021.108766_bib156","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108766_bib157","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2021.108766_bib158","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.toxlet.2020.07.028","article-title":"Methamphetamine induced neuroinflammation in mouse brain and microglial cell line BV2: roles of the TLR4\/TRIF\/Peli 1 signaling axis","volume":"333","author":"Yang","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2021.108766_bib159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbi.2017.11.010","article-title":"Angiotensin receptor blocker irbesartan reduces stress-induced intestinal inflammation via AT1a signaling and ACE2-dependent mechanism in mice","volume":"69","author":"Yisireyili","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108766_bib160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/(SICI)1096-9861(19990906)411:4<654::AID-CNE9>3.0.CO;2-H","article-title":"Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts","volume":"411","author":"Yu","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib161","series-title":"Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA\/SLE) Consortium","article-title":"IFN- \u03b3 and TNF- \u03b1 drive a CXCL10 + CCL2 + macrophage phenotype expanded in severe COVID-19 and other diseases with tissue inflammation","author":"Zhang","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108766_bib162","first-page":"1","article-title":"COVID-19 and gender-specific difference: analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020","author":"Zhao","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.neuropharm.2021.108766_bib163","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/npp.2010.116","article-title":"Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters","volume":"35","author":"Zhu","year":"2010","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082100321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082100321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:15:02Z","timestamp":1758438902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082100321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":162,"alternative-id":["S002839082100321X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108766","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Covid-19 interface with drug misuse and substance use disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108766"}}